	US 12,419,923 B2
	Bacteria
Heli Putaala, Kotka (FI); Sofia Forssten, Kotka (FI); Sampo Lahtinen, Kotka (FI); Arthur Ouwehand, Kotka (FI); Jaana Mättö, Helsinki (FI); Harri Mäkivuokko, Helsinki (FI); and Janne Nikkilä, Helsinki (FI)
Assigned to INTERNATIONAL N&HDENMARK APS, Kongens Lyngby (DK)
Filed by DUPONT NUTRITION BIOSCIENCES APS, Kongens Lyngby (DK)
Filed on Aug. 2, 2023, as Appl. No. 18/364,151.
Application 18/364,151 is a continuation of application No. 16/333,770, abandoned, previously published as PCT/EP2017/072859, filed on Sep. 12, 2017.
Claims priority of application No. 16189291 (EP), filed on Sep. 16, 2016.
Prior Publication US 2024/0245735 A1, Jul. 25, 2024
Int. Cl. A61K 35/747 (2015.01); A23L 33/00 (2016.01); A23L 33/135 (2016.01); A61K 35/745 (2015.01); A61P 1/04 (2006.01); A61P 1/12 (2006.01); A61P 1/14 (2006.01)

CPC A61K 35/747 (2013.01) [A23L 33/135 (2016.08); A23L 33/30 (2016.08); A61K 35/745 (2013.01); A61P 1/04 (2018.01); A61P 1/12 (2018.01); A61P 1/14 (2018.01)]

10 Claims

1. A method of preventing or treating a gastrointestinal disorder comprising: administering to a subject in need thereof a pharmaceutically effective amount of bacteria, wherein the bacteria comprise Lactobacillus acidophilus DSM 32111, Lactobacillus brevis DSM 32108, Lactobacillus brevis DSM 32107, Lactobacillus acidophilus DSM 32098, Lactobacillus fermentum DSM 32104, Lactobacillus fermentum DSM 32112, Lactobacillus fermentum DSM 32109, Lactobacillus fermentum DSM 32105, Lactobacillus fermentum DSM 32110, Lactobacillus gasseri DSM 32103, Lactobacillus mucosae DSM 32099, Lactobacillus paracasei DSM 32106, Lactobacillus paracasei DSM 32097, Lactobacillus rhamnosus DSM 32114 and/or Lactobacillus rhamnosus DSM 32115.